<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Radiation Research</title>
<title_fa>نشریه پرتو پژوه</title_fa>
<short_title>Int J Radiat Res</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ijrr.com</web_url>
<journal_hbi_system_id>79</journal_hbi_system_id>
<journal_hbi_system_user>journal79</journal_hbi_system_user>
<journal_id_issn>2322-3243</journal_id_issn>
<journal_id_issn_online>2345-4229</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/ijrr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1402</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2023</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<volume>21</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Stereotactic radiotherapy and cytokines: preliminary analysis in oligometastatic Non-Small-Cell lung cancer</title>
	<subject_fa>Radiation Biology</subject_fa>
	<subject>Radiation Biology</subject>
	<content_type_fa>تحقيق بديع</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;text-justify:newspaper&quot;&gt;&lt;span style=&quot;text-kashida-space:50%&quot;&gt;&lt;span style=&quot;line-height:119%&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Background&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Cytokines have a recognized role in the physiopathology of cancer disease and could be involved also in the &amp;ldquo;abscopal effect&amp;rdquo;. Aim of this work is the preliminary analysis of inflammatory mediators in patients with oligometastatic non-small-cell lung cancer (NSCLC) undergoing stereotactic radiotherapy (SRT). &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Materials&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;and Methods&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;This was a feasibility multi-institutional study that prospectively included oligometastatic NSCLC patients undergoing SRT from June 2018 until August 2018 and healthy controls. Blood samples were collected at three different time points (1-5 days before SRT, 1-5 days after SRT and 28-35 days after SRT). A commercially available kit was used for quantitative analysis of 44 inflammation molecules. Nine patients and four healthy controls were enrolled. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Results&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;&amp;nbsp; Several cytokines (54.5%) resulted undetectable in a significant percentage of the samples and were not further analyzed. Levels of seven inflammatory molecules (bDNF, MIP-1b, PDGF-bb, PIGF-1, RANTES, SDF1-a, and bNGF) showed significant variations after SRT in the NSCLC patients cohort. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Conclusion&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt; Significant plasmatic concentration changes after SRT were reported for a relevant proportion of the evaluated molecules. The results of this study will contribute to define a selection of cytokines and chemokines that will be analyzed in a prospective trial with a larger sample of patients.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Stereotactic radiotherapy, cytokines, oligometastatic, lung cancer.</keyword>
	<start_page>247</start_page>
	<end_page>254</end_page>
	<web_url>http://ijrr.com/browse.php?a_code=A-10-1-1035&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>P. </first_name>
	<middle_name></middle_name>
	<last_name>Borghetti</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023615</code>
	<orcid>7900319475328460023615</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, University and Spedali Civili Hospital of Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A.E. </first_name>
	<middle_name></middle_name>
	<last_name>Guerini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023616</code>
	<orcid>7900319475328460023616</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, University and Spedali Civili Hospital of Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A. </first_name>
	<middle_name></middle_name>
	<last_name>Colosini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>giorgio.facheris@gmail.com </email>
	<code>7900319475328460023617</code>
	<orcid>7900319475328460023617</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Molecular and Translational Medicine, Unit of Biotechnology, University of Brescia, Brescia, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>G. </first_name>
	<middle_name></middle_name>
	<last_name>Facheris</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023618</code>
	<orcid>7900319475328460023618</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Radiation Oncology, University and Spedali Civili Hospital of Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>C. </first_name>
	<middle_name></middle_name>
	<last_name>Gandolfo</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023619</code>
	<orcid>7900319475328460023619</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Microbiology Unit, Department of Medical Biotechnologies, University of Siena, Le Scotte Hospital, Siena, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>L. </first_name>
	<middle_name></middle_name>
	<last_name>Triggiani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023620</code>
	<orcid>7900319475328460023620</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, University and Spedali Civili Hospital of Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A. </first_name>
	<middle_name></middle_name>
	<last_name>Bruni</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023621</code>
	<orcid>7900319475328460023621</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Radiotherapy Unit, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>E. </first_name>
	<middle_name></middle_name>
	<last_name>D’Angelo</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023622</code>
	<orcid>7900319475328460023622</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Radiotherapy Unit, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>M. </first_name>
	<middle_name></middle_name>
	<last_name>Grazia Cusi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023623</code>
	<orcid>7900319475328460023623</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Microbiology Unit, Department of Medical Biotechnologies, University of Siena, Le Scotte Hospital, Siena, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>S.M. </first_name>
	<middle_name></middle_name>
	<last_name>Magrini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023624</code>
	<orcid>7900319475328460023624</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, University and Spedali Civili Hospital of Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>R. </first_name>
	<middle_name></middle_name>
	<last_name>Bresciani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023625</code>
	<orcid>7900319475328460023625</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Molecular and Translational Medicine, Unit of Biotechnology, University of Brescia, Brescia, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>V. </first_name>
	<middle_name></middle_name>
	<last_name>Nardone</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460023626</code>
	<orcid>7900319475328460023626</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Precision Oncology, University of Campania “L. Vanvitelli”, Naples, Italy</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
